Cbdmd Inc (YCBD) Stock Price, Quote & News

Company Profile

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States and internationally. The company owns and operates various consumer hemp-based CBD brands. Its cbdMD brand products include oils, gummies, capsules, soft-gels, topicals, functional formulations, and hemp-derived compliant Delta-9 THC products. It also provides products for dogs and cats, including tinctures, chews, and topicals under the Paw CBD brand name; non-cannabinoid functional ingredients, such as...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 704 445 3060

Website: www.cbdmd.com

Address:

2101 Westinghouse Blvd, Suite A, Charlotte, United States

zeph1985 Apr. 8 at 9:59 PM

$YCBD pmax.

0 · Reply

humblegambler Apr. 8 at 2:44 PM

$MSOS $YCBD marketcap only $7M. OracleNYSE Twitter account consistently tags cbdMD when mentioning Medicare access. https://www.prnewswire.com/news-releases/cbdmd-launches-clinical-healthcare-channel-to-support-first-federal-pathway-for-hemp-derived-cbd-in-medicare-302730460.html

0 · Reply

kingstonbull Apr. 6 at 3:49 PM

$YCBD Bluebird Botanicals has great products Know what you own

0 · Reply

GreenMadness00 Apr. 6 at 3:42 PM

$YCBD make a move

1 · Reply

humblegambler Apr. 2 at 6:07 PM

$YCBD shareholder stewardship has been unsatisfactory, but let’s see if they can deliver this time around with the policy landscape improving.

0 · Reply

humblegambler Apr. 2 at 6:05 PM

$YCBD reverse split is approved but not set in stone to happen. IMO it is not needed. Fundamentals can improve and they can dilute into the sector rally with less overall share issuance.

1 · Reply

FairytalePalaceTrades Apr. 2 at 5:11 PM

$YCBD will make a nice run in a couple weeks

0 · Reply

humblegambler Apr. 1 at 11:34 PM

$YCBD $1+ SOON

0 · Reply

PMReader Apr. 1 at 10:11 PM

$YCBD The board received enough votes for a reverse split. I am not waiting around for them to play that card. This is not a game for the hopeful.

1 · Reply

humblegambler Apr. 1 at 6:11 PM

$MSOS $CWBHF $YCBD https://www.cms.gov/newsroom/press-releases/cms-marks-milestone-expanding-patient-centered-innovation-substance-access-beneficiary-engagement

0 · Reply

cbdMD Launches Clinical Healthcare Channel to Support First Federal Pathway for Hemp-Derived CBD in Medicare

Feb 17, 2026, 4:10 PM EST - 7 weeks ago

cbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026

Feb 12, 2026, 5:31 PM EST - 7 weeks ago

cbdMD, Inc. to Host Conference Call to Discuss December 31, 2025 First Quarter Results

Feb 2, 2026, 9:00 AM EST - 2 months ago

cbdMD's Herbal Oasis Expands into Louisiana with Morales Beverage Group Following Strong Texas Momentum

Jan 29, 2026, 12:53 PM EST - 2 months ago

cbdMD Strengthens Regulatory Science Platform to Support Emerging Regulatory Cannabinoid Evaluation Pathways

Jan 14, 2026, 9:00 AM EST - 3 months ago

cbdMD Announces Strategic Acquisition of Bluebird Botanicals

Dec 19, 2025, 4:10 PM EST - 3 months ago

cbdMD Reports Third Consecutive Year of Operating Improvement, Strengthens Balance Sheet, and Regains NYSE American Continued Listing Compliance

Dec 19, 2025, 3:01 PM EST - 3 months ago

cbdMD, Inc. Announces Closing of $2.25 Million Series C Preferred Stock Private Placement

Dec 17, 2025, 7:16 PM EST - 4 months ago

cbdMD, Inc. to Host Conference Call to Discuss September 30, 2025, Fourth Quarter and Fiscal Year 2025 Results

Dec 8, 2025, 11:08 AM EST - 4 months ago

cbdMD, Inc. Regains Compliance with NYSE American Listing Standards

Nov 21, 2025, 8:30 AM EST - 4 months ago

cbdMD Reports Preliminary Unaudited Fourth Quarter and Fiscal 2025 Results

Oct 22, 2025, 10:03 AM EDT - 6 months ago

cbdMD's Herbal Oasis Hemp-Derived THC-Infused Social Seltzer Brand Expands its Product Offerings

Oct 9, 2025, 10:03 AM EDT - 6 months ago

cbdMD's Herbal Oasis Expands its Florida Footprint with Bevtalk Distribution Partnership

Oct 1, 2025, 4:15 PM EDT - 6 months ago

cbdMD, Inc. Announces Closing of $1.7 Million Series B Preferred Private Placement

Sep 25, 2025, 8:54 AM EDT - 6 months ago

cbdMD Announces Inferno Freeze: Our Most Powerful Topical

Sep 24, 2025, 10:00 AM EDT - 7 months ago

Herbal Oasis Expands Beyond the Southeast, Launches in Minnesota with Global Reserve Distribution

Sep 16, 2025, 10:00 AM EDT - 7 months ago

Herbal Oasis Expands into Tennessee with Best Brands

Aug 14, 2025, 4:07 PM EDT - 8 months ago

cbdMD Generates $4.6 Million of Revenue for the 3rd Quarter

Aug 12, 2025, 10:22 AM EDT - 8 months ago

cbdMD, Inc. to Host Conference Call to Discuss June 30, 2025, Third Quarter of Fiscal Year 2025 Results

Jun 24, 2025, 7:00 AM EDT - 10 months ago

cbdMD Expands Oasis Social Tonics to Total Wine

May 21, 2025, 7:00 AM EDT - 11 months ago

Herbal Oasis Expands Footprint with New Distribution Agreement in Georgia

May 15, 2025, 4:08 PM EDT - 11 months ago

cbdMD Delivers Continued Revenue Growth and Trend Towards Profitability in Second Fiscal Quarter

May 9, 2025, 12:57 PM EDT - 11 months ago

cbdMD, Inc. to Host Conference Call to Discuss March 31, 2025, Second Quarter of Fiscal Year 2025 Results

May 7, 2025, 11:04 AM EDT - 1 year ago

Herbal Oasis Expands Southeast Presence with New Distribution Agreement in North Carolina

Apr 24, 2025, 7:00 AM EDT - 1 year ago

Herbal Oasis Wins National Recognition at the 2025 High Spirits Awards

Apr 21, 2025, 8:20 PM EDT - 1 year ago

cbdMD, Inc. Announces Automatic Conversion Date of Series A Preferred Stock and One for Eight Reverse Split of its Common Stock Immediately Following the Automatic Conversion

Apr 10, 2025, 5:57 PM EDT - 1 year ago

cbdMD, Inc. Announces Shareholder Approval of Automatic Conversion of Series A Preferred Stock and Other Results from Annual Meeting

Apr 7, 2025, 7:00 AM EDT - 1 year ago

cbdMD Achieves Key Milestone in UK Novel Food Regulatory Approval

Feb 13, 2025, 4:10 PM EST - 1 year ago

cbdMD Generates $5.1 Million in Revenue, Positive Earnings

Feb 7, 2025, 5:26 PM EST - 1 year ago

cbdMD, Inc. to Host Conference Call to Discuss December 31, 2024 First Quarter of Fiscal Year 2025 Results

Jan 15, 2025, 10:30 AM EST - 1 year ago

cbdMD Announces It Has Fully Satisfied Its Notes

Jan 8, 2025, 5:22 PM EST - 1 year ago

cbdMD Announces Additional Conversions of Its Convertible Notes

Jan 3, 2025, 4:44 PM EST - 1 year ago

cbdMD, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standard

Dec 23, 2024, 3:52 PM EST - 1 year ago

cbdMD Announces Company's CEO Joins the Board of Directors

Dec 18, 2024, 4:08 PM EST - 1 year ago

cbdMD Generates $19.1 Million in Year Over Year Reduction in Net Loss Improvement

Dec 18, 2024, 11:04 AM EST - 1 year ago

cbdMD, Inc. to Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 Results

Dec 17, 2024, 4:42 PM EST - 1 year ago

cbdMD, Inc. Reschedules Earnings Release and Conference Call

Dec 12, 2024, 12:12 PM EST - 1 year ago

cbdMD, Inc. To Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 Results

Nov 14, 2024, 2:26 PM EST - 1 year ago

cbdMD Launches Herbal Oasis Social Tonics, Hemp-Derived THC Seltzers

Aug 26, 2024, 4:25 PM EDT - 1 year ago

cbdMD, Inc. Announces Acceptance of Compliance Plan by NYSE American

Aug 14, 2024, 4:10 PM EDT - 1 year ago

cbdMD Delivers on Sequential Revenue Growth and Positive Net Income for Q3 2024

Aug 5, 2024, 11:03 AM EDT - 1 year ago

cbdMD, Inc. to Host Conference Call to Discuss Third Quarter of Fiscal 2024 Results

Jun 27, 2024, 11:45 AM EDT - 1 year ago

cbdMD Announces Publication of Human Clinical Trial Data

Jun 7, 2024, 5:36 PM EDT - 1 year ago

cbdMD, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards

May 24, 2024, 10:03 AM EDT - 2 years ago

cbdMD Unveils ATRx Labs Premium Mushroom Line at GNC, Expanding cbdMD's Natural Wellness Solutions

May 16, 2024, 10:37 AM EDT - 2 years ago

cbdMD Launches Max Chill Dragon Fruit D9 Gummies: Your Go-To Relaxation Blend for the Summer

May 15, 2024, 4:09 PM EDT - 2 years ago

cbdMD Reports Second Quarter Results

May 13, 2024, 11:20 AM EDT - 2 years ago

cbdMD, Inc. to Host Conference Call to Discuss Second Quarter of Fiscal 2024 Results

Feb 13, 2024, 4:10 PM EST - 2 years ago

cbdMD Reduces Year over Year Net Loss from Operations by $3.0 Million

Feb 8, 2024, 4:05 PM EST - 2 years ago

cbdMD, Inc. to Host Conference Call to Discuss First Quarter of Fiscal 2024 Results

zeph1985 Apr. 8 at 9:59 PM

$YCBD pmax.

0 · Reply

humblegambler Apr. 8 at 2:44 PM

0 · Reply

kingstonbull Apr. 6 at 3:49 PM

$YCBD Bluebird Botanicals has great products Know what you own

0 · Reply

GreenMadness00 Apr. 6 at 3:42 PM

$YCBD make a move

1 · Reply

humblegambler Apr. 2 at 6:07 PM

$YCBD shareholder stewardship has been unsatisfactory, but let’s see if they can deliver this time around with the policy landscape improving.

0 · Reply

humblegambler Apr. 2 at 6:05 PM

$YCBD reverse split is approved but not set in stone to happen. IMO it is not needed. Fundamentals can improve and they can dilute into the sector rally with less overall share issuance.

1 · Reply

FairytalePalaceTrades Apr. 2 at 5:11 PM

$YCBD will make a nice run in a couple weeks

0 · Reply

humblegambler Apr. 1 at 11:34 PM

$YCBD $1+ SOON

0 · Reply

PMReader Apr. 1 at 10:11 PM

$YCBD The board received enough votes for a reverse split. I am not waiting around for them to play that card. This is not a game for the hopeful.

1 · Reply

humblegambler Apr. 1 at 6:11 PM

$MSOS $CWBHF $YCBD https://www.cms.gov/newsroom/press-releases/cms-marks-milestone-expanding-patient-centered-innovation-substance-access-beneficiary-engagement

0 · Reply

humblegambler Apr. 1 at 5:55 PM

$YCBD “To the Company's knowledge, no other hemp-derived CBD manufacturer has published both OECD-standard preclinical toxicology data and human randomized controlled trial data for its commercial product lines.“ Worth a read $MSOS

0 · Reply

GreenMadness00 Apr. 1 at 1:37 PM

$YCBD https://www.prnewswire.com/news-releases/cbdmd-launches-clinical-healthcare-channel-to-support-first-federal-pathway-for-hemp-derived-cbd-in-medicare-302730460.html

0 · Reply

JL_TradeZ Apr. 1 at 12:58 PM

CBD names are getting some attention. White House is reviewing an FDA proposal on compliance and enforcement. Meetings today and tomorrow. Nothing finalized yet, but this is how themes start building. Watching how it plays out. $SBEV $TLRY $YCBD $AKAN $CGC

1 · Reply

Renium Mar. 31 at 8:47 PM

$YCBD Cen we get back to $2?

0 · Reply

kingstonbull Mar. 31 at 8:25 PM

$YCBD See ya at 3.50

0 · Reply

GreenMadness00 Mar. 31 at 12:46 AM

$YCBD we gunna dip and rip or is my $150K worthless

0 · Reply

nottoday800 Mar. 30 at 11:57 PM

$YCBD just gotta hope they dont reverse split on us

1 · Reply

StonkCapital Mar. 30 at 9:51 PM

$YCBD The 2026 annual shareholders' meeting occurred on March 30, 2026 (today), where proposals—including the reverse split authorization—were voted on and passed. However, no specific ratio has been selected or announced yet by the board, and the split has not been effected. The board has up to one year from the meeting date to decide and implement it if they choose.

0 · Reply

Renium Mar. 30 at 5:51 PM

$YCBD Annoying

0 · Reply

kingstonbull Mar. 30 at 3:44 PM

$YCBD Bluebird botanicals is a brand I’ve used for over a year now- great customer service, easy purchases and cancellations, great product. I go with what I know

0 · Reply

GreenMadness00 Mar. 30 at 2:05 PM

$YCBD

0 · Reply

humblegambler Mar. 30 at 1:54 PM

$YCBD yes

0 · Reply

Market Cap	7.51M
Revenue (ttm)	19.19M
Net Income (ttm)	-2.04M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-10.63%
Debt to Equity Ratio	0.00

Volume	139,200
Avg Vol	1,050,614
Day's Range	N/A - N/A
Shares Out	10.50M
Stochastic %K	36%
Beta	2.09
Analysts	Strong Sell
Price Target	$2.00